Peer review reports
From: The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
| Original Submission |
| 23 Sep 2022 |
Submitted |
Original manuscript
|
| 5 Nov 2022 |
Author responded |
Author comments - Haiyan Liu
|
| Resubmission - Version 2 |
| 5 Nov 2022 |
Submitted |
Manuscript version 2
|
| Publishing |
| 11 Nov 2022 |
Editorially accepted |
|
| 30 Nov 2022 |
Article published |
10.1186/s12888-022-04388-y
|
Learn about peer review
